US FDA Approves GSK’s Pandemic H1N1 Vaccine

GlaxoSmithKline (GSK) today announced that the US Food and Drug Administration (FDA) has approved a supplemental biologics license application (sBLA) for its unadjuvanted influenza A (H1N1) pandemic vaccine.

The details can be read here.